Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study

Peer Review reports

Original Submission
11 Sep 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
22 Oct 2021	Reviewed	Reviewer Report - Zurab Azmaiparashvili
28 Jan 2022	Reviewed	Reviewer Report
26 Feb 2022	Author responded	Author comments - Kei Sato
Resubmission - Version 3
26 Feb 2022	Submitted	Manuscript version 3
3 Mar 2022	Author responded	Author comments - Kei Sato
Resubmission - Version 4
3 Mar 2022	Submitted	Manuscript version 4
Publishing
16 Mar 2022	Editorially accepted
23 Mar 2022	Article published	10.1186/s12872-022-02565-1

Back to article page